Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires04:54

PBMs Generated Billions in Drug Markups, FTC Says -- Barrons.com

Barron's04:34

Update: Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says

MT Newswires02:05

USA Trade Commission: Pharmacies significantly raised the prices of medications for heart disease, cancer, and other conditions.

The USA Federal Trade Commission stated on Tuesday that the three major Pharmaceutical benefit management Institutions in the USA, including UnitedHealth Group (UNH.US), CVS Health (CVS.US), and Cigna (CI.US), have significantly raised the prices of some drugs at their pharmacies, including those for heart disease, cancer, and HIV. The Commission noted that from 2017 to 2022, UnitedHealth's Optum, CVS Health's CVS Caremark, and Cigna's Express Scripts raised their pharmacy prices multiple times to several tens of times, leading to net revenues exceeding the Pharmaceutical.

AASTOCKS01:42

FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role, Shares Down

Yahoo Finance01:16

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says -- WSJ

WSJ00:38